Novo Nordisk, Emcure Pharma to launch weight-loss drug under new brand in India

Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra, the second brand of Wegovy.

Novo Nordisk, Emcure Pharma to launch weight-loss drug under new brand

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...
Pharmabiz

Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra in India as a second brand of Wegovy

Our Bureau, Mumbai Monday, November 10, 2025, 12:45 Hrs [IST] ...
The Financial Express

Novo Nordisk partners Emcure Pharma to commercialise weight loss drug Poviztra in India

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...
Healthcare Dive

Novo, Lilly cut deal with Trump to lower prices of obesity drugs

The outgoing Biden administration in its waning days sought to extend Medicare and Medicaid coverage to Wegovy and Zepbound, but the Trump administration shelved that effort. The deal announced ...